FAVIPIRAVIR

Name: FAVIPIRAVIR
Availability: favipiravir-252992.html

Category:Active Pharmaceutical Ingredients > Other Anti-Infective Drug
Product Name:FAVIPIRAVIR
CAS No.:259793-96-9
Standard:In-house Standards
Price(USD):Negotiable
Company:Hangzhou Bio-Bounce Technology Co., Ltd

Send Inquiry

Favorites

Similar Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Zhejiang

Main Sales Markets: Central/South America,Asia,Middle East
Sample Provided: no

Payment Terms: L/L

Discovered by Toyama Chemical Co., Ltd. in Japan, favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza. The antiviral targets RNA-dependent RNA polymerase (RdRp) enzymes, which are necessary for the transcription and replication of viral genomes. Not only does favipiravir inhibit replication of influenza A and B, but the drug has shown promise in the treatment of avian influenza, and may be an alternative option for influenza strains that are resistant to neuramidase inhibitors. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19.

Send your message to this supplier

From:
To:
Hangzhou Bio-Bounce Technology Co., Ltd
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

FAVIPIRAVIR

You may like